These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37841777)

  • 1. Clinical importance of serum and pleural fluid prominin-1 and hypoxia-inducible factor-1α concentration in the evaluation of lymph node involvement in patients with malignant pleural effusion.
    Ozmen ZC; Kupeli M
    Biochem Med (Zagreb); 2023 Oct; 33(3):030701. PubMed ID: 37841777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of B7-H4 and carcinoembryonic antigen in diagnosing the benign and malignant pleural effusion].
    Wei F; Wei Y; Li LF; Li GL; Wang GJ
    Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):524-527. PubMed ID: 28728299
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study.
    Fan X; Liu Y; Liang Z; Wang S; Yang J; Wu A
    Pathol Oncol Res; 2022; 28():1610280. PubMed ID: 35515016
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-free DNA methylation analysis as a marker of malignancy in pleural fluid.
    Bixby B; Vrba L; Lenka J; Oshiro MM; Watts GS; Hughes T; Erickson H; Chopra M; Knepler JL; Knox KS; Jarnagin L; Alalawi R; Kala M; Bernert R; Routh J; Roe DJ; Garland LL; Futscher BW; Nelson MA
    Sci Rep; 2024 Feb; 14(1):2939. PubMed ID: 38316884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro-cathepsin D as a diagnostic marker in differentiating malignant from benign pleural effusion: a retrospective cohort study.
    Choi H; Ko Y; Lee CY
    BMC Cancer; 2020 Aug; 20(1):825. PubMed ID: 32867726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
    Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
    J Proteomics; 2024 Jun; 302():105201. PubMed ID: 38768894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a machine learning model for differential diagnosis of malignant pleural effusion using routine laboratory data.
    Wei TT; Zhang JF; Cheng Z; Jiang L; Li JY; Zhou L
    Ther Adv Respir Dis; 2023; 17():17534666231208632. PubMed ID: 37941347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum and pleural levels tumor M2-pyruvate kinase in lung cancer patients with pleural effusion.
    Zhang T; Liu W; Li L; Jue Z; Xu C
    BMC Pulm Med; 2022 Aug; 22(1):307. PubMed ID: 35948914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic accuracy of pleural fluid to serum carcinoembryonic antigen ratio and delta value for malignant pleural effusion: findings from two cohorts.
    Jiang MP; Wen JX; Hai L; Jiang TW; Huang JH; Chen H; Wang YF; Zheng WQ; Hu ZD; Yan L
    Ther Adv Respir Dis; 2023; 17():17534666231155745. PubMed ID: 36927281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of a panel of miRNAs in serum and pleural fluid for the differential diagnosis of malignant and benign pleural effusion.
    Zhu LR; Yuan RX; Xia XB; Wang Y; Zhu YM; Fi L; Li J
    Cancer Biomark; 2022; 33(1):71-82. PubMed ID: 34366325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidine kinase 1 concentration in pleural effusion is a diagnostic marker and survival predictor for malignant pleural effusion.
    Tian T; Li J; Hu W; Sun C; Zhou J
    J Clin Lab Anal; 2019 Jul; 33(6):e22901. PubMed ID: 30985967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the diagnosis value of carcinoembryonic antigen in malignant pleural effusion].
    Yu YX; Tong ZH; Zhou XX; Liang LR; Wang Z; Xu LL; Wang XJ; Wu YB; Li HJ; Lu Z
    Zhonghua Yi Xue Za Zhi; 2018 Feb; 98(6):432-435. PubMed ID: 29429254
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of PET/MRI in the diagnosis of malignant pleural effusion in comparison with PET/CT].
    Peng WB; Sun X; Zhou M; Wei XS; Wu XZ; Ruan WW; Shi HZ; Lan XL; Zhou Q
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(30):2363-2369. PubMed ID: 34404128
    [No Abstract]   [Full Text] [Related]  

  • 15. Combined Methylation of
    Zhong Q; Wang Y; Liang C; Wei F; She B
    Discov Med; 2023 Oct; 35(178):845-852. PubMed ID: 37811622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput autoantibody analysis in malignant pleural effusion and tuberculosis pleural effusion.
    Yi F; Zhang X
    Medicine (Baltimore); 2019 Sep; 98(38):e17253. PubMed ID: 31567996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant Pleural Effusion at Presentation in Patients with Small-Cell Lung Cancer.
    Shojaee S; Singh I; Solsky I; Nana-Sinkam P
    Respiration; 2019; 98(3):198-202. PubMed ID: 31121583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Label-Free Quantitative Proteomics Identifies Novel Biomarkers for Distinguishing Tuberculosis Pleural Effusion from Malignant Pleural Effusion.
    Pan L; Zhang X; Jia H; Huang M; Liu F; Wang J; Du B; Wei R; Sun Q; Xing A; Li Q; Zhang Z
    Proteomics Clin Appl; 2020 Jan; 14(1):e1900001. PubMed ID: 31715074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypoxia-inducible factor-1α and CD133 predicts pathological complete response and survival for locally advanced rectal cancer patients after neoadjuvant chemoradiotherapy].
    Cai C; Wang J; Zhong Z; Dai Z; Wang Q; Dong W; Shi H; Liu Q; DU J
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 46(1):36-43. PubMed ID: 28436629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
    Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
    In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.